Search

everythinglearnresearchcommunity

for

Search:↓

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Phytoconstituents from Cyperus Rotundus may help treat hirsutism by interacting with the 5 α reductase enzyme.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

A CCS patient with severe complications was successfully treated using combined therapies.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Lack of cystatin M/E causes thin hair and dry skin.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Cimetidine did not reduce hair growth in women with hirsutism.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Minoxidil-loaded nanoparticles improve hair loss treatment by enhancing delivery and reducing irritation.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Cnicus Benedictus leaf extract can kill cervical cancer cells without harming normal cells.